Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
BAFF CAR-T for Non-Hodgkin Lymphoma
Recruiting1 awardPhase 1
Cleveland, Ohio
This trial is testing a new immune cell therapy for patients with non-Hodgkin lymphoma who haven't responded to other treatments. The therapy involves modifying the patient's own immune cells to better recognize and attack their cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service